CompletedPhase 2

Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children

Egypt100 participantsStarted 2005-12

Plain-language summary

The purpose of this study is to determine the effectiveness of nitazoxanide suspension compared to placebo in treating rotavirus disease in pediatric patients less than 6 years of age.

Who can participate

Age range5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \< 6 years. * Patients with diarrhea (defined as 3 or more liquid stools per day). * Stool positive for rotavirus by ELISA. Exclusion Criteria: * Other identified causes of diarrhea at screening (pathogenic protozoa, bacteria, viruses or lactose intolerance). * Serious systemic disorders incompatible with the study.

What they're measuring

Time from first dose to resolution of symptoms.

Timeframe: Up to 14 days

Trial details

NCT IDNCT01328925

SponsorRomark Laboratories L.C.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-06

View on ClinicalTrials.gov More Rotavirus Infection trials